39
Views
18
CrossRef citations to date
0
Altmetric
Review

Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention

, &
Pages 277-290 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jong Ryul Eun, Heon Ju Lee, Hee Jung Moon, Tae Nyeun Kim, Jae Woon Kim & Jay Chun Chang. (2009) Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Scandinavian Journal of Gastroenterology 44:12, pages 1477-1486.
Read now

Articles from other publishers (17)

Yasuteru Kondo, Tatsuki Morosawa, Soichiro Minami & Yasuhito Tanaka. (2022) DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC. Scientific Reports 12:1.
Crossref
Jennifer L. Steel, Feridey N. Carr, Alexandra Savkova, Naadia Ahmed, Andrea DiMartini & Mary A. Dew. 2016. Hepatocellular Carcinoma. Hepatocellular Carcinoma 547 577 .
Toshifumi Tada, Takashi Kumada, Hidenori Toyoda, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Shusuke Kitabatake & Tsuyoki Yama. (2015) Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis. Journal of Gastroenterology and Hepatology 30:9, pages 1412-1419.
Crossref
Guoliang Qiao, Jun Li, Aiming Huang, Zhenlin Yan, Wan-Yee Lau & Feng Shen. (2014) An artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 29:12, pages 2014-2020.
Crossref
Arb-aroon Lertkhachonsuk, Cheng Har Yip, Thiravud Khuhaprema, Ding-Shinn Chen, Martyn Plummer, Sun Ha Jee, Masakazu Toi & Sarikapan Wilailak. (2013) Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. The Lancet Oncology 14:12, pages e497-e507.
Crossref
Long Lv, Ping Wang, Xiaoqing Zhou & Beicheng Sun. (2013) Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk. Tumor Biology 34:3, pages 1451-1459.
Crossref
Toru Ishikawa. (2010) Antibiotic Prophylaxis and the Clinical Meaning after Transcatheter Treatment for Hepatocellular Carcinoma: Indicated?. Internal Medicine 49:12, pages 1049-1050.
Crossref
Jue Wang, Fenwei Wang & Anne Kessinger. (2010) Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver. Journal of Oncology 2010, pages 1-7.
Crossref
Jennifer L. Steel, Andrea DiMartini & Mary Amanda Dew. 2010. Hepatocellular Carcinoma. Hepatocellular Carcinoma 641 711 .
Naveen Ballem, Eren Berber, Tracy Pitt & Allan Siperstein. (2008) Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up. HPB 10:5, pages 315-320.
Crossref
Noriyo Yamashiki, Haruhiko Yoshida, Ryosuke Tateishi, Shuichiro Shiina, Takuma Teratani, Hideo Yoshida, Yuji Kondo, Takamasa Oki, Takao Kawabe & Masao Omata. (2007) Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. Journal of Gastroenterology and Hepatology 22:12, pages 2155-2160.
Crossref
Yuji Kondo, Haruhiko Yoshida, Ryosuke Tateishi, Shuichiro Shiina, Norio Mine, Noriyo Yamashiki, Shinpei Sato, Naoya Kato, Fumihiko Kanai, Mikio Yanase, Hideo Yoshida, Masatoshi Akamatsu, Takuma Teratani, Takao Kawabe & Masao Omata. (2007) Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 22:2, pages 197-203.
Crossref
Shuntaro Obi, Haruhiko Yoshida, Risa Toune, Tadao Unuma, Miho Kanda, Shinpei Sato, Ryosuke Tateishi, Takuma Teratani, Shuichiro Shiina & Masao Omata. (2006) Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 106:9, pages 1990-1997.
Crossref
Zhi-Jun Zeng. (2004) Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World Journal of Gastroenterology 10:23, pages 3414.
Crossref
Cui-Ping Zhang, Zi-Bin Tian, Xi-Shuang Liu, Qing-Xi Zhao, Jun Wu & Yong-Xin Liang. (2004) Effects of zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis . World Journal of Gastroenterology 10:2, pages 295.
Crossref
Yasushi Shiratori. 2004. Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma. Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma 219 228 .
Ramachandra S. Hosmane. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.